Sunday, 19 January 2014

Aurobindo Pharma rallies nearly 7% on Actavis acquisition plans

Aurobindo Pharma rallied as much as 6.8 per cent, after the generics drug maker signed a binding offer agreement to acquire Actavis.



from Stocks-Markets-The Economic Times http://ift.tt/1jls6yh

No comments:

Post a Comment